KR940014436A - 2-아미노-6,7-디히드록시-4-티아헵탄산 유도체, 그의 제조방법 및 용도 - Google Patents

2-아미노-6,7-디히드록시-4-티아헵탄산 유도체, 그의 제조방법 및 용도 Download PDF

Info

Publication number
KR940014436A
KR940014436A KR1019930030357A KR930030357A KR940014436A KR 940014436 A KR940014436 A KR 940014436A KR 1019930030357 A KR1019930030357 A KR 1019930030357A KR 930030357 A KR930030357 A KR 930030357A KR 940014436 A KR940014436 A KR 940014436A
Authority
KR
South Korea
Prior art keywords
compound
amino
amino acid
aliphatic acyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019930030357A
Other languages
English (en)
Korean (ko)
Inventor
세이이찌 다니다
스네아끼 히다
미쓰히로 와끼마스
세쓰오 하라다
고이찌 유끼시게
Original Assignee
다께다 구니오
다께다야꾸힝고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다께다 구니오, 다께다야꾸힝고오교 가부시끼가이샤 filed Critical 다께다 구니오
Publication of KR940014436A publication Critical patent/KR940014436A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019930030357A 1992-12-28 1993-12-28 2-아미노-6,7-디히드록시-4-티아헵탄산 유도체, 그의 제조방법 및 용도 Withdrawn KR940014436A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP92-349062 1992-12-28
JP34906292 1992-12-28
JP93-56185 1993-03-16
JP5618593 1993-03-16
JP93-181735 1993-07-22
JP18173593 1993-07-22

Publications (1)

Publication Number Publication Date
KR940014436A true KR940014436A (ko) 1994-07-18

Family

ID=27295829

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930030357A Withdrawn KR940014436A (ko) 1992-12-28 1993-12-28 2-아미노-6,7-디히드록시-4-티아헵탄산 유도체, 그의 제조방법 및 용도

Country Status (15)

Country Link
US (1) US5478808A (cg-RX-API-DMAC10.html)
EP (1) EP0604957B1 (cg-RX-API-DMAC10.html)
KR (1) KR940014436A (cg-RX-API-DMAC10.html)
CN (1) CN1094731A (cg-RX-API-DMAC10.html)
AT (1) ATE170871T1 (cg-RX-API-DMAC10.html)
AU (1) AU666789B2 (cg-RX-API-DMAC10.html)
CA (1) CA2112523A1 (cg-RX-API-DMAC10.html)
DE (1) DE69320931T2 (cg-RX-API-DMAC10.html)
FI (1) FI935888A7 (cg-RX-API-DMAC10.html)
HU (1) HUT65865A (cg-RX-API-DMAC10.html)
IL (1) IL108173A (cg-RX-API-DMAC10.html)
NO (1) NO934834L (cg-RX-API-DMAC10.html)
NZ (1) NZ250588A (cg-RX-API-DMAC10.html)
PH (1) PH30687A (cg-RX-API-DMAC10.html)
TW (1) TW264479B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6977292B2 (en) * 2000-09-01 2005-12-20 Gryphon Therapeutics Nucleophile-stable thioester generating compounds, methods of production and use
EP1382352A1 (de) * 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Bisacyloxypropylcystein-Konjugate und deren Verwendung
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
US8008260B2 (en) 2005-06-13 2011-08-30 Cleveland Clinic Foundation Methods of protecting against apoptosis using lipopeptides
US8299129B2 (en) 2006-03-01 2012-10-30 Fukuoka Prefectural Government Peptide lipid-containing carrier and method for introducing compound into cells using same
DE102009034779A1 (de) * 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
EA031379B1 (ru) * 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000330B1 (de) * 1977-06-20 1981-08-05 Ciba-Geigy Ag Lipopeptide, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Präparate
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
ATE67769T1 (de) * 1983-01-25 1991-10-15 Ciba Geigy Ag Neue peptidderivate.
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
JPH0446194A (ja) * 1990-06-13 1992-02-17 Fujisawa Pharmaceut Co Ltd Ｗｓ１２７９ａ物質、その生産法及び用途
JPH0499796A (ja) * 1990-08-13 1992-03-31 Kazuo Achinami 新規リポペプタイド及び抗腫瘍剤
SG47406A1 (en) * 1991-12-19 1998-04-17 Ciba Geigy Ag Aminosulfonic acid derivatives and processes for their preparation

Also Published As

Publication number Publication date
FI935888A0 (fi) 1993-12-27
IL108173A (en) 1998-03-10
HU9303761D0 (en) 1994-04-28
TW264479B (cg-RX-API-DMAC10.html) 1995-12-01
NZ250588A (en) 1995-03-28
NO934834L (no) 1994-06-29
EP0604957B1 (en) 1998-09-09
DE69320931D1 (de) 1998-10-15
US5478808A (en) 1995-12-26
CA2112523A1 (en) 1994-06-29
ATE170871T1 (de) 1998-09-15
HUT65865A (en) 1994-07-28
FI935888L (fi) 1994-06-29
NO934834D0 (no) 1993-12-27
AU5261493A (en) 1994-07-07
PH30687A (en) 1997-09-16
CN1094731A (zh) 1994-11-09
FI935888A7 (fi) 1994-06-29
EP0604957A1 (en) 1994-07-06
DE69320931T2 (de) 1999-05-20
IL108173A0 (en) 1994-04-12
AU666789B2 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
DE69010375T2 (de) Protease-Hemmer.
RU92016217A (ru) Двойные ингибиторы no синтазы и циклооксигеназы, способ их получения и фармацевтическая композиция на их основе
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
NL990025I2 (nl) Sulfamaatderivaten met anticonvulsieve werking.
PT81793B (pt) Processo para a preparacao de novos derivados peptidicos com estrutura policiclica azotada
PT93502A (pt) Processo para a preparacao de novos derivados de insulina e de composicoes farmaceuticas que os contem
KR910009712A (ko) 세펨 화합물 및 이의 제조방법
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
EA199801000A1 (ru) Производные алкиламинобензотиазола и -бензоксазола
ES8200868A1 (es) Un procedimiento para la preparacion de un derivado de aze- tidina
SE8604950D0 (sv) Dementia-improving and therapeutic agents
ES8704917A1 (es) Procedimiento para prepararar derivados de 1-piperazinacarboximida.
EA200101241A1 (ru) Производные индола
KR960022498A (ko) 에스큘레틴 유도체, 그의 제조방법 및 약학조성물
ATE37533T1 (de) Derivate der 4-phenyl-4-oxo-buten-2-saeure, verfahren zu ihrer herstellung, medikamente und mischungen mit diesen derivaten.
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
KR920004402A (ko) 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법
RU94032285A (ru) Цефалоспориновые соединения, способ их получения, фармацевтическая композиция
KR890014561A (ko) 세펨 화합물 및 이의 제조방법
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
ES8300681A1 (es) Procedimiento para preparar amidas.
FI935888A0 (fi) 2-amino-6,7-dihydroxi-4-tiaheptansyraderivat, deras framstaellning och anvaendning
DE3465297D1 (en) Derivatives of n-(methoxyphenacyl)amine, their therapeutical use and process for their preparation
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
RU95112451A (ru) Фенилэтил- и фенилпропиаминовые соединения, способ их получения, фармацевтическая композиция и способ лечения

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000